28. Treatment of Non-Tuberculous Mycobacterium Infections

  1. Deepali Kumar MD, MSc, FRCPC and
  2. Atul Humar MD, MSc, FRCPC
  1. Nina M. Clark MD

Published Online: 5 MAY 2011

DOI: 10.1002/9781444397949.ch28

The AST Handbook of Transplant Infections

The AST Handbook of Transplant Infections

How to Cite

Clark, N. M. (2011) Treatment of Non-Tuberculous Mycobacterium Infections, in The AST Handbook of Transplant Infections (eds D. Kumar and A. Humar), Wiley-Blackwell, Oxford, UK. doi: 10.1002/9781444397949.ch28

Editor Information

  1. Transplant Infectious Diseases, University of Alberta, Edmonton, Canada

Author Information

  1. Department of Internal Medicine, University of Illinois at Chicago, Chicago, IL, USA

Publication History

  1. Published Online: 5 MAY 2011
  2. Published Print: 13 MAY 2011

ISBN Information

Print ISBN: 9780470658277

Online ISBN: 9781444397949



  • treatment of non-tuberculous mycobacterium infections;
  • test isolate for CLARI susceptibility;
  • M. aviumintracellulare complex (MAC);
  • M. abscessus lung disease - difficulty in curing;
  • AZ, azithromycin;
  • criteria for NTM prophylaxis - and treatment regimens, not systematically studied in organ transplant recipients;
  • RGM, identified to species level - differences in treatment recommendations, undergoing susceptibility testing;
  • AZ favored over CLARI and rifabutin favored - over RIF, few drug interactions;
  • treating pulmonary disease - until sputum cultures, negative over 12-month period;
  • TIG, tigecycline